SE421997B - Forfarande for framstellning av renat albumin genom termokoagulering - Google Patents

Forfarande for framstellning av renat albumin genom termokoagulering

Info

Publication number
SE421997B
SE421997B SE7309451A SE7309451A SE421997B SE 421997 B SE421997 B SE 421997B SE 7309451 A SE7309451 A SE 7309451A SE 7309451 A SE7309451 A SE 7309451A SE 421997 B SE421997 B SE 421997B
Authority
SE
Sweden
Prior art keywords
purated
thermocoagulation
albumin
preparing
procedure
Prior art date
Application number
SE7309451A
Other languages
English (en)
Swedish (sv)
Inventor
R Plan
J Liautaud
M-F Makula
P Gattel
J Pla
A Debrus
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of SE421997B publication Critical patent/SE421997B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7309451A 1972-07-05 1973-07-04 Forfarande for framstellning av renat albumin genom termokoagulering SE421997B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7224311A FR2190437B1 (da) 1972-07-05 1972-07-05

Publications (1)

Publication Number Publication Date
SE421997B true SE421997B (sv) 1982-02-15

Family

ID=9101388

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7309451A SE421997B (sv) 1972-07-05 1973-07-04 Forfarande for framstellning av renat albumin genom termokoagulering

Country Status (17)

Country Link
US (1) US3992367A (da)
JP (1) JPS5312965B2 (da)
AR (1) AR195041A1 (da)
BE (1) BE801888A (da)
BR (1) BR7305002D0 (da)
CA (1) CA1028320A (da)
DE (1) DE2333883C3 (da)
DK (1) DK134425B (da)
ES (1) ES416597A1 (da)
FR (1) FR2190437B1 (da)
GB (1) GB1441751A (da)
LU (1) LU67931A1 (da)
NL (1) NL179874C (da)
NO (1) NO140579C (da)
RO (1) RO64629A (da)
SE (1) SE421997B (da)
SU (1) SU591126A3 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415079C3 (de) * 1974-03-28 1980-02-14 Plasmesco Ag, Zug (Schweiz) Verfahren zum Isolieren von Albumin aus Blutplasma
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
US4197238A (en) * 1977-04-12 1980-04-08 The Green Cross Corporation Method of preparation of human albumin using polyethylene glycol
US4164496A (en) * 1978-08-23 1979-08-14 American National Red Cross Preparation of albumin using PEG and EDTA
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4222934A (en) * 1979-04-12 1980-09-16 American National Red Cross Preparation of albumin using ethanol
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
JPS6152702U (da) * 1984-09-12 1986-04-09
JPS62294621A (ja) * 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US4791191A (en) * 1987-11-12 1988-12-13 Plasmatech Corporation Depyrogenation of clinical albumin
FR2632308B1 (fr) * 1988-06-07 1991-08-16 Fondation Nale Transfusion San Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines
JPH0253505U (da) * 1988-10-12 1990-04-18
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
JP4935242B2 (ja) * 2006-08-24 2012-05-23 ニプロ株式会社 脂肪酸を含有するｓ−ニトロソタンパク質とその製法
WO2018165766A1 (en) 2017-03-16 2018-09-20 Therapure Biopharma Inc. Method for purification of albumin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US2705230A (en) * 1949-09-23 1955-03-29 Allen F Reid Method of purifying albumin
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2765299A (en) * 1952-06-27 1956-10-02 Armour & Co Recovery of serum albumin
US2761810A (en) * 1954-07-22 1956-09-04 Ortho Pharma Corp Preparation of blood fraction for use in rh testing procedures
US2958628A (en) * 1957-02-21 1960-11-01 Cutter Lab Heat treatable plasma protein product and method of preparation
US3100737A (en) * 1958-02-05 1963-08-13 Auerswald Wilhelm Method of preparing a plasma protein solution free of active hepatitis virus and product produced thereby
US3497492A (en) * 1968-04-02 1970-02-24 American Cyanamid Co Preparation of placental albumin
JPS5220524B1 (da) * 1968-11-02 1977-06-04

Also Published As

Publication number Publication date
NL7309361A (da) 1974-01-08
DK134425B (da) 1976-11-08
FR2190437B1 (da) 1975-08-08
NL179874C (nl) 1986-12-01
RO64629A (fr) 1979-02-15
NL179874B (nl) 1986-07-01
FR2190437A1 (da) 1974-02-01
DE2333883A1 (de) 1974-01-31
DK134425C (da) 1977-04-12
BE801888A (fr) 1974-01-04
CA1028320A (en) 1978-03-21
JPS5312965B2 (da) 1978-05-06
US3992367A (en) 1976-11-16
DE2333883C3 (de) 1983-05-11
NO140579B (no) 1979-06-25
AR195041A1 (es) 1973-08-30
NO140579C (no) 1979-10-03
ES416597A1 (es) 1976-03-01
GB1441751A (en) 1976-07-07
BR7305002D0 (pt) 1974-08-15
DE2333883B2 (de) 1982-09-16
SU591126A3 (ru) 1978-01-30
LU67931A1 (da) 1975-04-11
JPS4985219A (da) 1974-08-15

Similar Documents

Publication Publication Date Title
SE421997B (sv) Forfarande for framstellning av renat albumin genom termokoagulering
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397530B (sv) Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat
NO139124C (no) Fremgangsmaate for fremstilling av estere
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
SE423540B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE7611202L (sv) Forfarande for framstellning av pyrazolodiazepinforeningar
FI55626B (fi) Anordning foer framstaellning av en behaollare
NO137279C (no) Fremgangsm}te for oppberedning av findelte polyolefiner
NO139130C (no) Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner
SE415146B (sv) Forfarande for framstellning av forbettrad epoxideringskatalysator
SE387344B (sv) Forfarande for framstellning av pyrazin-4-oxidderivat
SE385581B (sv) Forfarande for framstellning av foretrade n-metylolkarbamidforeningar
IT999554B (it) Procedimento per preparare diacetossibutano
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen
DK136061C (da) Fremgangsmade til fremstilling af 2,6-diamino-dihydropyridiner
SE417960B (sv) Forfarande for framstellning av sulfamoylfenyl-imidazolidinoner
NO141951C (no) Fremgangsmaate for oppslutning av loev-ved.
IT1033071B (it) Procedimento per prepare tiazolsolfenammidi
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
SE415974B (sv) Forfarande for framstellning av 2-bensoyl-3-amino-pyridinderivat
SE419441B (sv) Forfarande for framstellning av butyrofenonderivat
NO137073C (no) Fremgangsm}te for fremstilling av en innleggss}le